Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap-Reference-Cited by-同舟云学术

Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap

Published:2017-04 Issue: Volume:52 Page:119-131
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Frisoni Giovanni B.,Perani Daniela,Bastianello Stefano,Bernardi Gaetano,Porteri Corinna,Boccardi Marina^ORCID,Cappa Stefano F.,Trabucchi Marco^ORCID,Padovani Alessandro

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference80 articles.

1. Clinical core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans;Aisen;Alzheimers Dement.,2010

2. Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol;Apostolova;Alzheimers Dement.,2015

3. Donepezil-induced confusional state in a patient with autopsy-proven behavioral-variant frontotemporal dementia;Arciniegas;J. Neuropsychiatry Clin. Neurosci.,2013

4. Technical validation of a fully automated Roche Elecsys immunoassay for the quantitative determination of amyloid-beta 1-42 in human cerebro-spinal fluid;Bittner;Neurodegener Dis.,2015

5. Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance;Boccardi;Alzheimers Dement.,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Transition of Mild Cognitive Impairment Over Time: An AV45- and FDG-PET Study of Reversion and Conversion Phenomena;Current Alzheimer Research;2021-08

2. A method for diagnosis support of mild cognitive impairment through EEG rhythms source location during working memory tasks;Biomedical Signal Processing and Control;2021-04

3. The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update;European Journal of Nuclear Medicine and Molecular Imaging;2021-03-10

4. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers;European Journal of Nuclear Medicine and Molecular Imaging;2021-03-06

5. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework;European Journal of Nuclear Medicine and Molecular Imaging;2021-03-05